ALFA Filings
Every announcement, straight from the exchange
Every iSERA Lifesciences capital structure change announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Promoters and directors of iSERA Lifesciences acquired shares through a preferential offer valued at ₹113.98 Crore. This transaction changes the company's capital structure.
Promoter Pratap Dadasaheb Deshmukh acquired 86.13 lakh shares via preferential allotment. His stake in iSERA Lifesciences shifted to 55.07% following the company's capital restructuring.
iSERA Lifesciences Limited approved the allotment of 1,61,82,800 equity shares on a preferential basis. The allotment, priced at Rs. 48.20 per share, total Rs. 78.00 Crore.
Covidh Technologies Limited has officially changed its name to iSERA Lifesciences Limited effective April 10, 2026. The Registrar of Companies, Pune, approved the change and the consequent alteration of the company's Memorandum and Articles of Association. This rebranding follows a special resolution passed by members at an EGM on April 2, 2026.